Diabetes in acromegaly, prevalence, risk factors, and evolution: Data from the French Acromegaly Registry

European Journal of Endocrinology

Volumn 164, Issue 6, 2011, Pages 877-884

  Fieffe, Sandrine ^a   Morange, Isabelle ^b   Petrossians, Patrick ^c   Chanson, Philippe ^d   Rohmer, Vincent ^e   Cortet, Christine ^f   Borson Chazot, Françoise ^g   Brue, Thierry ^b   Delemer, Brigitte ^a   Sonnet, E ^h   Cazabat, L ⁱ   Hieronimus, S ^j   Gaillard, R ^k   Enjalbert, A ^b   Raingeard, I ^l   Dupuy, O ^m   Beckers A , ^c  

^a SERVICE DE DERMATOLOGIE   (France)

^b TIMONE HOSPITAL   (France)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d BICÊTRE HOSPITAL   (France)

^e ANGERS UNIVERSITY HOSPITAL   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g Hopital de l'Antiquaille   (France)

^h BREST UNIVERSITY HOSPITAL   (France)

ⁱ Cochin Hospital ^*  (France)

^j CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^k CHU de Lausanne   (France)

^l MONTPELLIER UNIVERSITY HOSPITAL   (France)

^m Hôpital d'Instruction des Armées Béguin   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INSULIN; METFORMIN; PROLACTIN; SOMATOMEDIN C; SULFONYLUREA;

ACROMEGALY; AGE; ARTICLE; BELGIUM; BODY MASS; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DISEASE DURATION; DRUG WITHDRAWAL; FEMALE; FRANCE; GENDER; HORMONE DEFICIENCY; HUMAN; HYPERTENSION; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REGISTER; RHEUMATIC DISEASE; RISK FACTOR; SWITZERLAND; TUMOR VOLUME; ADULT; AGE DISTRIBUTION; AGED; DISEASE ASSOCIATION; DISEASE REGISTRY; PREDICTION;

ACROMEGALY; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BODY MASS INDEX; CHILD; DATABASES, FACTUAL; DIABETES COMPLICATIONS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMAN GROWTH HORMONE; HUMANS; HYPERTENSION; INSULIN-LIKE GROWTH FACTOR I; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PITUITARY NEOPLASMS; REGISTRIES; RISK FACTORS; SEX RATIO; YOUNG ADULT;

EID: 79957784185     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-1050     Document Type: Article

References (34)

1. Melmed S. Medical progress: acromegaly. New England Journal of Medicine 2006 355 2558-2573. (doi:10.1056/NEJMra062453)
2. Colao A, Ferone D, Marzullo P & Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews 2004 25 102-152. (doi:10.1210/er.2002-0022)
3. Holdaway IM, Rajasoorya RC & Gamble GD. Factors influencing mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism 2004 89 667-674. (doi:10.1210/jc.2003-031199)
4. Puder JJ, Nilavar S, Post KD & Freda PU. Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2005 90 1972-1978. (doi:10.1210/jc.2004-2009)
5. Dekkers OM, Biermasz NR, Pereira AM, Romijn JA & Vandenbroucke JP. Mortality in acromegaly: a metaanalysis. Journal of Clinical Endocrinology and Metabolism 2008 93 61-67. (doi:10.1210/jc.2007-1191)
6. Møller N & Jorgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews 2009 30 152-177. (doi:10.1210/er.2008-0027)
7. Jaffrain-Rea ML, Moroni C, Baldelli R, Battista C, Maffei P, Terzolo M, Correra M, Ghiggi MR, Ferretti E, Angeli A, Sicolo N, Trischitta V, Liuzzi A, Cassone R & Tamburrano G. Relationship between blood pressure and glucose tolerance in acromegaly. Clinical Endocrinology 2001 54 189-195. (doi:10.1046/j.1365-2265.2001.01206.x)
8. Jaffrain-Rea M, Minniti G, Moroni C, Esposito V, Ferretti E, Santoro A, Infusino T, Tamburrano G, Cantore G & Cassone R. Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly. European Journal of Endocrinology/European Federation of Endocrine Societies 2003 148 193-201. (Pubitemid 36305685)
9. Drange MR, Fram NR, Herman-Bonert V & Melmed S. Pituitary tumor registry: a novel clinical resource. Journal of Clinical Endocrinology and Metabolism 2000 85 168-174. (doi:10.1210/jc.85.1.168)
10. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Werder KV & Melmed S. Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2000 85 526-529. (doi:10.1210/jc.85.2.526)
11. World health organization: Definition, diagnosis and classification of diabetes mellitus and its com- plications: Report of a WHO consultation. part 1: Diagnosis and classification of diabetes mellitus. Geneva, World Health Org. 1999.
12. Kusnik-Joinville O, Weill A, Salanave B, Ricordeau P & Allemand H. Prevalence and treatment of diabetes in france: trends between 2000 and 2005. Diabetes and Metabolism 2008 34 266-272. (doi:10.1016/j.diabet.2008.01.005)
13. Bringer J, Fontaine P, Detournay B, Nachit-Ouinekh F, Brami G & Eschwege E. Prevalence of diagnosed type 2 diabetes mellitus in the French general population: the INSTANT study. Diabetes and Metabolism 2009 35 25-31. (doi:10.1016/j.diabet.2008.06.004)
14. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA & Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. Journal of Clinical Endocrinology and Metabolism 2006 91 4769-4775. (doi:10.1210/jc.2006-1668)
15. Alexander L, Appleton D, Hall R, Ross WM & Wilkinson R. Epidemiology of acromegaly in the newcastle region. Clinical Endocrinology 1980 12 71-79. (doi:10.1111/j.1365-2265.1980.tb03135.x)
16. Bengtsson BA, Edén S, Ernest I, Odén A & Sjögren B. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Medica Scandinavica 1988 223 327-335. (doi:10.1111/j.0954-6820.1988.tb15881.x)
17. Nabarro JD. Acromegaly. Clinical Endocrinology 1987 26 481-512. (doi:10.1111/j.1365-2265.1987.tb00805.x)
18. Holdaway IM & Rajasoorya C. Epidemiology of acromegaly. Pituitary 1999 2 29-41. (doi:10.1023/A:1009965803750)
19. Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S, Gomez J-M, Halperin I, Lucas-Morante T, Moreno B, Obiols G, de Pablos P, Paramo C, Pico A, Torres E, Varela C, Vazquez J-A, Zamora J, Albareda M & Gilabert M. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish acromegaly registry (Registro Espanol De Acromegalia, Rea). European Journal of Endocrinology 2004 151 439-446. (doi:10.1530/eje.0.1510439)
20. Bex M, Abs R, T'Sjoen G, Mockel J, Velkeniers B, Muermans K & Maiter D. Acrobel-the belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects. European Journal of Endocrinology 2007 157 399-409. (doi:10.1530/EJE-07-0358)
21. Wass JA, Cudworth AG, Bottazzo GF,Woodrow JC & Besser GM. An assessment of glucose intolerance in acromegaly and its response to medical treatment. Clinical Endocrinology 1980 12 53-59. (doi:10.1111/j.1365-2265.1980. tb03132.x)
22. Biering H, Knappe G, Gerl H & Lochs H. Prevalence of diabetes in acromegaly and cushing syndrome. Acta Medica Austriaca 2000 27 27-31. (doi:10.1046/j.1563-2571.2000.00106.x)
23. Møller N, Schmitz O, Jøorgensen JO, Astrup J, Bak JF, Christensen SE, Alberti KG & Weeke JO. Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. Journal of Clinical Endocrinology and Metabolism 1992 74 1012-1019. (doi:10.1210/jc.74.5.1012)
24. Dominici FP, Argentino DP, Muñoz MC, Miquet JG, Sotelo AI & Turyn D. Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity. Growth Hormone & IGF Research 2005 15 324-336. (doi:10.1016/j.ghir.2005.07.001)
25. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W & Le Roith D. Liver-specific IGF-1 gene deletion leads to muscle insulin insensitivity. Diabetes 2001 50 1110-1118. (doi:10.2337/diabetes.50.5. 1110)
26. Neggers SJ & van der Lely AJ. Modulation of glucocorticoid metabolism by the GH-IGF-I axis. Endocrine Development 2011 20 181-186. (doi:10.1159/000321243)
27. Ronchi C, Epaminonda P, Cappiello V, Beck-Peccoz P & Arosio M. Effects of two different somatostatin analogs on glucose tolerance in acromegaly. Journal of Endocrinological Investigation 2002 25 502-507. (Pubitemid 34661837)
28. Colao A, Auriemma RS, Galdiero M, Lombardi G & Pivonello R. Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: a prospective study. Journal of Clinical Endocrinology and Metabolism 2009 94 3746-3756. (doi:10.1210/jc.2009-0941)
29. Colao A, Auriemma RS, Savastano S, Galdiero M, Grasso LF, Lombardi G & Pivonello R. Glucose tolerance and somatostatin analog treatment in acromegaly: a 12-month study. Journal of Clinical Endocrinology and Metabolism 2009 94 2907-2914. (doi:10.1210/jc.2008-2627)
30. Mazziotti G, Porcelli T, Bogazzi F, Bugari G, Cannavo S, Colao A, Cozzi R, De Marinis L, degli Uberti E, Grottoli S, Minuto F, Montini M, Spinello M & Giustina A. Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy. European Journal of Endocrinology 2011 164 341-347. (doi:10.1530/EJE-10-0811)
31. Kinoshita Y, Fujii H, Takeshita A, Taguchi M, Megumi M, Oyama K, Yamada S & Takeuchi Y. Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic {beta}-cell function is preserved. European Journal of Endocrinology 2011 164 467-473. (doi:10. 1530/EJE-10-1096)
32. Colao A, Auriemma RS, Galdiero M, Cappabianca P, Cavallo LM, Esposito F, Grasso LF, Lombardi G & Pivonello R. Impact of somatostatin analogs vs surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study. Journal of Clinical Endocrinology and Metabolism 2009 94 528-537. (doi:10.1210/jc.2008-1546)
33. Gordon DA, Hill FM & Ezrin C. Acromegaly: a review of 100 cases. Canadian Medical Association Journal 1962 87 1106-1109.
34. Vitale G, Pivonello R, Auriemma RS, Guerra E, Milone F, Savastano S, Lombardi G & Colao A. Hypertension in acromegaly and in the normal population: prevalence and determinants. Clinical Endocrinology 2005 63 470-476. (doi:10.1111/j.1365-2265.2005.02370.x)